Xiaojing Wang

3.9k total citations · 1 hit paper
34 papers, 768 citations indexed

About

Xiaojing Wang is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pharmacology. According to data from OpenAlex, Xiaojing Wang has authored 34 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Pathology and Forensic Medicine and 6 papers in Pharmacology. Recurrent topics in Xiaojing Wang's work include Cancer Mechanisms and Therapy (4 papers), Synthesis and biological activity (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Xiaojing Wang is often cited by papers focused on Cancer Mechanisms and Therapy (4 papers), Synthesis and biological activity (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Xiaojing Wang collaborates with scholars based in China, United States and Spain. Xiaojing Wang's co-authors include Chen Shen, Yu Cheng, Hongsheng Gao, Xuehao Chen, Tongqi Li, Changyi Zhao, Zhijie Zhao, Xiaohua Dong, Xinyuan Li and Ruizhe Zheng and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Clinical Cancer Research.

In The Last Decade

Xiaojing Wang

33 papers receiving 746 citations

Hit Papers

A Review of Classification, Biosynthesis, Biological Acti... 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojing Wang China 16 304 182 134 113 101 34 768
Qingdi Quentin Li China 18 393 1.3× 111 0.6× 183 1.4× 66 0.6× 55 0.5× 28 841
Mohamed E. Shaker Egypt 20 334 1.1× 106 0.6× 126 0.9× 172 1.5× 59 0.6× 60 1.0k
Edwina N. Scott United Kingdom 10 430 1.4× 88 0.5× 281 2.1× 72 0.6× 60 0.6× 12 956
Shin‐Hyung Park South Korea 19 557 1.8× 78 0.4× 162 1.2× 77 0.7× 116 1.1× 57 1.1k
Te-Mao Li Taiwan 18 394 1.3× 69 0.4× 124 0.9× 65 0.6× 109 1.1× 20 877
M. Margaret Juliana United States 17 440 1.4× 109 0.6× 173 1.3× 69 0.6× 105 1.0× 31 868
Jung Ho Back United States 10 619 2.0× 140 0.8× 168 1.3× 72 0.6× 58 0.6× 10 1.2k
Marina Orlandi Italy 14 442 1.5× 90 0.5× 87 0.6× 118 1.0× 85 0.8× 26 770
Rhonda J. Rosengren New Zealand 16 470 1.5× 121 0.7× 187 1.4× 104 0.9× 128 1.3× 32 943
Ying‐Jan Wang Taiwan 15 423 1.4× 83 0.5× 115 0.9× 62 0.5× 79 0.8× 22 828

Countries citing papers authored by Xiaojing Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaojing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Wang more than expected).

Fields of papers citing papers by Xiaojing Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Wang. The network helps show where Xiaojing Wang may publish in the future.

Co-authorship network of co-authors of Xiaojing Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojing Wang. A scholar is included among the top collaborators of Xiaojing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojing Wang. Xiaojing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaojing, et al.. (2024). Inhibition of cc chemokine receptor 10 ameliorates osteoarthritis via inhibition of the phosphoinositide-3-kinase/Akt/mammalian target of rapamycin pathway. Journal of Orthopaedic Surgery and Research. 19(1). 158–158. 4 indexed citations
2.
Chandarlapaty, Sarat, Maura N. Dickler, José Alejandro Pérez Fidalgo, et al.. (2023). An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor–Positive Breast Cancer. Clinical Cancer Research. 29(15). 2781–2790. 7 indexed citations
3.
Shen, Chen, Xiaojing Wang, Yu Cheng, Hongsheng Gao, & Xuehao Chen. (2023). A Review of Classification, Biosynthesis, Biological Activities and Potential Applications of Flavonoids. Molecules. 28(13). 4982–4982. 199 indexed citations breakdown →
4.
Sun, Jie, et al.. (2023). Synthesis and activity of arylcoumarin derivatives with therapeutic effects on diabetic nephropathy. Archiv der Pharmazie. 357(3). 1 indexed citations
5.
Lopez, Hector L., Neil Aronin, Yanli Ding, et al.. (2022). A RET::GRB2 fusion in pheochromocytoma defies the classic paradigm of RET oncogenic fusions. Cell Reports Medicine. 3(7). 100686–100686. 5 indexed citations
6.
Ren, Yijun, et al.. (2022). The distribution and speciation of dissolved Cd and Pb in the Bohai Sea and Yellow Sea, China. Marine Pollution Bulletin. 186. 114437–114437. 3 indexed citations
7.
Zhao, Zhijie, Tongqi Li, Xiaohua Dong, et al.. (2021). Untargeted Metabolomic Profiling of Cuprizone‐Induced Demyelination in Mouse Corpus Callosum by UPLC‐Orbitrap/MS Reveals Potential Metabolic Biomarkers of CNS Demyelination Disorders. Oxidative Medicine and Cellular Longevity. 2021(1). 7093844–7093844. 38 indexed citations
8.
Miao, Yu‐Hang, et al.. (2021). Synthesis and biological evaluation of 2-arylbenzofuran derivatives as potential anti-Alzheimer’s disease agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1345–1355. 15 indexed citations
9.
Wang, Xiaojing, Yaqin Yang, María‐Aránzazu Martínez, et al.. (2021). Interaction Between Florfenicol and Doxycycline Involving Cytochrome P450 3A in Goats (Capra hricus). Frontiers in Veterinary Science. 8. 759716–759716. 3 indexed citations
10.
Wang, Chen, Xiaojing Wang, Liwen Zhang, et al.. (2020). Intrinsic and Extrinsic Programming of Product Chain Length and Release Mode in Fungal Collaborating Iterative Polyketide Synthases. Journal of the American Chemical Society. 142(40). 17093–17104. 22 indexed citations
11.
Wang, Xiaojing, et al.. (2020). Main Traits of Breast Fibroadenoma Among Adolescent Girls. Cancer Biotherapy and Radiopharmaceuticals. 35(4). 271–276. 6 indexed citations
12.
Zheng, Siyuan, Kristin Alfaro-Munoz, Wei Wei, et al.. (2019). Prospective Clinical Sequencing of Adult Glioma. Molecular Cancer Therapeutics. 18(5). 991–1000. 15 indexed citations
13.
Wang, Xiaojing, Chen Wang, Lixin Duan, et al.. (2019). Rational Reprogramming ofO-Methylation Regioselectivity for Combinatorial Biosynthetic Tailoring of Benzenediol Lactone Scaffolds. Journal of the American Chemical Society. 141(10). 4355–4364. 37 indexed citations
14.
Takahashi, Ryan, Xiaojing Wang, Nathaniel L. Segraves, et al.. (2017). CYP1A1-Mediated Intramolecular Rearrangement of Aminoazepane in GDC-0339. Drug Metabolism and Disposition. 45(10). 1084–1092. 6 indexed citations
15.
Slebos, Robbert J.C., Xia Wang, Xiaojing Wang, et al.. (2015). Proteomic analysis of colon and rectal carcinoma using standard and customized databases. Scientific Data. 2(1). 150022–150022. 21 indexed citations
16.
Hu, Huiyong, Xiaojing Wang, Jae H. Chang, et al.. (2015). Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(22). 5258–5264. 19 indexed citations
17.
Halvey, Patrick J., Xiaojing Wang, Jing Wang, et al.. (2013). Proteogenomic Analysis Reveals Unanticipated Adaptations of Colorectal Tumor Cells to Deficiencies in DNA Mismatch Repair. Cancer Research. 74(1). 387–397. 41 indexed citations
18.
Wang, Xiaojing, Steven Magnuson, Huiyong Hu, et al.. (2013). Discovery of novel pyrazolo[1,5-a]pyrimidines as potent pan-Pim inhibitors by structure- and property-based drug design. Bioorganic & Medicinal Chemistry Letters. 23(11). 3149–3153. 55 indexed citations
19.
Thackaberry, Evan A., Xiaojing Wang, Michelle Schweiger, et al.. (2013). Solvent-based formulations for intravenous mouse pharmacokinetic studies: tolerability and recommended solvent dose limits. Xenobiotica. 44(3). 235–241. 31 indexed citations
20.
Wu, Tao, Hai Bai, Qian Zhang, et al.. (2009). [Autologous bone marrow-derived mesenchymal stem cells and peripheral blood stem cells cotransplantation in treatment of hematological malignant diseases].. PubMed. 48(5). 392–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026